we would like to inform that Directors in their meeting held on 14th November, 2023 have inter alia transacted the following matters: 1. Approved the Unaudited Standalone Financial Results of the Company for the Second Quarter and Half Year Ended 30th September, 2023. 2. Approved the Unaudited Consolidated Financial Results of the Company for the Second Quarter and Half Year Ended 30th September, 2023. 3. Limited Review Reports of the Statutory Auditors on the Standalone & Consolidated Financial Results of the Company for the Second Quarter and Half Year Ended 30th September, 2023, issued by the Statutory Auditors, Pavan & Associates as required under Regulation 33 of the Listing Regulations.